Search for: "Medimmune Inc"
Results 1 - 20
of 248
Sort by Relevance
|
Sort by Date
5 Dec 2022, 6:55 am
Citing the Supreme Court’s ruling in MedImmune, Inc. v. [read post]
5 Dec 2022, 6:55 am
Citing the Supreme Court’s ruling in MedImmune, Inc. v. [read post]
5 Dec 2022, 6:55 am
Citing the Supreme Court’s ruling in MedImmune, Inc. v. [read post]
29 Jun 2022, 1:41 am
The Supreme Court denies petitions for writ of certiorari without stating the reasons. [read post]
24 Feb 2022, 6:12 pm
This question ties the case directly to MedImmune, Inc. v. [read post]
8 Feb 2022, 1:54 pm
Adkins, 395 U.S. 653 (1969); & MedImmune, Inc. v. [read post]
20 Dec 2021, 8:42 am
Hazeltine Research, Inc., 401 U.S. 321 (1971) (antitrust – patent pools – waiver of defenses); MedImmune, Inc. v. [read post]
14 Dec 2021, 9:57 am
As you can see, this question attempts to tie the case directly to MedImmune, Inc. v. [read post]
10 Nov 2021, 12:15 pm
Court of Appeals for the Federal Circuit (CAFC) today dismissed Apple, Inc. [read post]
26 Oct 2021, 6:53 am
Did the court of appeals err in adopting a new and inflexible rule,contrary to normal standing rules and this Court’s decision in MedImmune, Inc. [read post]
7 Jun 2021, 6:36 am
The en banc petition focuses on the Supreme Court’s patent-licensee standing decision in MedImmune, Inc. v. [read post]
19 May 2021, 10:40 am
”) Now, Apple has petitioned the Federal Circuit for en banc rehearing, arguing that the outcome is contrary to MedImmune Inc. v. [read post]
7 Apr 2021, 9:30 am
In MedImmune, Inc. v. [read post]
3 Aug 2020, 7:02 am
The parties’ experts, Professor Patrick Wheeler of Nottingham University for Lufthansa and Mr Douglas Hay Barovsky of Engineering Systems Inc. for the Defendants disagreed on many points, in particular the identity of the skilled person. [read post]
2 Jun 2020, 1:50 pm
Later, in MedImmune, Inc. v. [read post]
28 Apr 2020, 11:46 pm
by Olivia Henry and Nicholas Michelmore On 20 April 2020, Arnold LJ (sitting as a High Court Judge) gave judgment in the case between FibroGen Inc and Astellas Pharma Inc (together the “Claimants”), and Akebia Therapeutics Inc and Otsuka Pharmaceutical Company Limited (together the “Defendants”) which concerned six patents owned by FibroGen and exclusively licensed to Astellas (the “Patents”). [read post]
17 Sep 2018, 10:27 am
(citing MedImmune, Inc. v. [read post]
24 May 2018, 8:53 pm
Noonan -- Ever since the Supreme Court loosened the reins on declaratory judgment actions in patent cases twelve years ago, in MedImmune v. [read post]
18 Feb 2018, 7:45 pm
Google Inc.[11]. [read post]
18 Feb 2018, 11:30 am
Search, Inc., 173 F. [read post]